Natco Pharma Ltd has informed BSE regarding a Press Release dated December 15, 2015 titled 'NATCO receives generic Ledipasvir + Sofosbuvir approval for India'.
Ask Value Research 
News Announcement
Natco Pharma: NATCO receives generic Ledipasvir + Sofosbuvir approval for India
15-Dec-2015
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
